Keywords

cholesterol reduction, diabetes, dyslipidemia, endocrine, hyperlipidemia, macrovascular risk reduction, primary care, statin therapy, type 2 diabetes mellitus

Authors

1. Frank, Michelle L. MSN, APRN, FNP-C
2. Gerhardt, Annie M. DNP, APRN, FNP-C

Abstract

Abstract: Type 2 diabetes mellitus is associated with significant cardiovascular morbidity and mortality. Diabetic dyslipidemia is a major cause of cardiovascular complications and a key area for intervention. The blood cholesterol treatment guideline released in 2013 and strategies to reduce cardiovascular risk are outlined and addressed in this article.